Giant Cell Tumor of Tendon Sheath
"Giant Cell Tumor of Tendon Sheath" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor arising in the SYNOVIAL MEMBRANE; SYNOVIAL BURSA; or TENDON sheath. It is characterized by OSTEOCLAST-like GIANT CELLS; FOAM CELLS; pigmented HEMOSIDERIN-laden MACROPHAGES and inflammatory infiltrate. It is classified either as diffuse or localized tenosynovitis.
| Descriptor ID |
D000070779
|
| MeSH Number(s) |
C04.557.450.565.380.690 C05.550.870.445 C05.651.869.762
|
| Concept/Terms |
Localized Giant Cell Tumor of the Tendon Sheath- Localized Giant Cell Tumor of the Tendon Sheath
- Localized Nodular Tenosynovitis
- Localized Nodular Tenosynovitides
- Nodular Tenosynovitides, Localized
- Nodular Tenosynovitis, Localized
- Tenosynovitides, Localized Nodular
- Tenosynovitis, Localized Nodular
- Localized Pigmented Villonodular Synovitis
- Nodular Tenosynovitis
- Nodular Tenosynovitides
- Tenosynovitides, Nodular
- Tenosynovitis, Nodular
|
Below are MeSH descriptors whose meaning is more general than "Giant Cell Tumor of Tendon Sheath".
Below are MeSH descriptors whose meaning is more specific than "Giant Cell Tumor of Tendon Sheath".
This graph shows the total number of publications written about "Giant Cell Tumor of Tendon Sheath" by people in this website by year, and whether "Giant Cell Tumor of Tendon Sheath" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Giant Cell Tumor of Tendon Sheath" by people in Profiles.
-
Caldwell TM, Ahn YM, Bulfer SL, Leary CB, Hood MM, Lu WP, Vogeti L, Vogeti S, Kaufman MD, Wise SC, Le Bourdonnec B, Smith BD, Flynn DL. Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT). Bioorg Med Chem Lett. 2022 10 15; 74:128928.
-
Smith BD, Kaufman MD, Wise SC, Ahn YM, Caldwell TM, Leary CB, Lu WP, Tan G, Vogeti L, Vogeti S, Wilky BA, Davis LE, Sharma M, Ruiz-Soto R, Flynn DL. Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages. Mol Cancer Ther. 2021 11; 20(11):2098-2109.